chinext a touch of warm sunshine after the cold winter
TRANSCRIPT
-
8/14/2019 ChiNext a Touch of Warm Sunshine After the Cold Winter
1/15
Zero2IPO Insight
ChiNext:
A Touch of Warm Sunshine after the Cold Winter
On Oct. 30th, 2009, with the long-waiting ChiNext finally setting sail, the first batch of 28 ChiNext-listed companies will go public together on the
Shenzhen Stock Exchange. After the cold winter of financial crisis, the launch of ChiNext brings a touch of warm sunshine to Chinese VC/PE industry.
All of the Stock Prices of ChiNext-listed Enterprises in First Batch Soared at the Opening with Their Average Opening Price Rising 76.5%
from Issue Price.
From Oct. 30th, 28 stocks have been officially listed on ChiNext. In the first trading day, all of stock prices surged. There was an average increase of
76.5% in opening prices compared with issue prices, among which Huayi Brothers topped the competition with an opening price of RMB63.66, 122.7%
higher than its issue price. In addition, five stocks enjoyed an increase of more than 100.0% in opening price, including Anke Biotechnology, Toread,
EVE Battery, Lepu Medical and Huaxing Chuangye; five stocks saw opening price rising by 80.0%-100.0%, accounting for 17.9% of all, which were
respectively Shenyang Siaxun, Dayu Water-saving, Gifore, Geeya Technology and Beijing Dinghan Technology; 15 stocks enjoyed an increase of
50.0%-80.0% in opening prices, accounting for 53.6%; and only two stocks were up below 50.0%.
Table 1 First Batch of 28 ChiNext-listed Enterprises
1
-
8/14/2019 ChiNext a Touch of Warm Sunshine After the Cold Winter
2/15
Zero2IPO Insight
StockCode
Company Name Headquarters Grade-1Industry
IssuePrice
P/ERatio
SharesIssued(10,000shares)
Opening Price
GrowthRate
VC/PE Institution
300027 Huayi Brothers Beijing Services 28.58 69.71 4,200 63.66 122.74% China Equity
300009 AnkeBiotechnolgoy
Anhui Bio/Healthcare
17.00 46.83 2,100 37.00 117.65% Good VC
300005 Beijing Toread Beijing Traditional 19.80 53.10 1,700 42.00 112.12% LeadingInvestment
300014 Eve Battery Guangdong(ExcludingShenzhen)
Clean-tech
18.00 54.56 2,200 38.00 111.11% CMTECH,Fortune VC
300003 Lepu Medical Beijing Bio/Healthcare
29.00 59.56 4,100 61.00 110.34% Warburg Pincus
2
-
8/14/2019 ChiNext a Touch of Warm Sunshine After the Cold Winter
3/15
Zero2IPO Insight
300025 Huaxing Chuangye Zhejiang Broad IT 19.66 45.18 1,000 40.00 103.46%
300024 Shenyang Siaxun Liaoning Broad IT 39.80 62.90 1,550 74.00 85.93% Gold StoneInvestment
300021 Dayu Water-saving Gansu Traditional 14.00 53.85 1,800 25.60 82.86%
300022 Gifore Sichuan Services 17.75 57.26 2,240 32.25 81.69% Jiuding Capital
300028 Geeya Technology Sichuan Broad IT 11.30 45.20 3,700 20.50 81.42% Xinao VC,Hangyuanfu VC,
Dehui Investment,
Jiaze Investment,
Florin Investmen,
Fengze
Investment,
Jiuding Capital
300011 Beijing DinghanTechnology
Beijing Broad IT 37.00 82.22 1,362 66.70 80.27% China VentureCapitalXingye VC
300001 TGOOD Electric Shandong Traditional 23.80 52.76 3,500 42.00 76.47% Qingdao LaoshanTechnologyInvestment
300015 Aier Ophthalmology
Hunan Bio/Healthcare
28.00 60.87 3,350 48.86 74.50% IFC
Fortune VC
300017 ChinaNetCenter Shanghai Broad IT 24.00 63.16 2,300 41.50 72.92% CDF-Capital,Fortune VC, VIC,Fuwei VCSZVC, FortuneVC
300002 Ultrapower Beijing Broad IT 58.00 68.80 3,160 100.10 72.59% Huijinlifang andGold Stone
300006 LummyPharmaceuticals
Chongqing Bio/Healthcare
16.50 47.83 2,300 27.45 66.36% ChongqingTechnology VC
3
-
8/14/2019 ChiNext a Touch of Warm Sunshine After the Cold Winter
4/15
Zero2IPO Insight
300023 Bode EnergyEquipment
Shaanxi Traditional 19.60 81.67 1,500 32.56 66.12%
300019 Chengdu Guibao Sichuan Traditional 23.00 47.96 1,300 38.01 65.26%
300007 Henan HanweiElectronics
Henan Traditional 27.00 60.54 1,500 44.00 62.96% Ningbo JunrunInvestment
300016 Beilu Beijing Bio/Healthcare
17.86 47.89 1,700 29.00 62.37% Beijing VentureCapitalInfotech
300026 Chase Sun Tianjin Bio/Healthcare
60.00 49.18 1,259 97.15 61.92% TJVC
300013 Xinning Logistics Jiangsu Traditional 15.60 45.48 1,500 24.50 57.05% JinrongInvestmentTaihe Investment,Yiwen VentureCapital, NingheInvestment
300010 Lanxum Beijing Broad IT 18.00 51.49 2,650 28.10 56.11% China-Belgium
Fund300008 Bestway Marine Shanghai Services 27.80 40.12 1,260 43.15 55.22% Shanghai Zichen
Investment300020 Silver River Zhejiang Broad IT 20.00 52.63 2,000 31.00 55.00% ZVC, Haitong
Kaiyuan, ZhejiangLanshanIntel Capital
300004 Nanfang Veni lator Guangdong(ExcludingShenzhen)
Traditional 22.89 46.24 2,400 35.00 52.91% Tongying VC
300012 Center TestingInternational
Shenzhen Traditional 25.78 59.95 2,100 38.00 47.40%
300018 ZhongyuanHuadian
Hubei Traditional 32.18 52.62 1,635 47.00 46.05% China-BelgiumFund
Source: Zero2IPO Research Center 2009.10 www.zero2ipo.com.cn
A Total of 46 VC/PE Institutions Once Invested in the 23 of the First-batch ChiNext-listed Enterprises.
4
-
8/14/2019 ChiNext a Touch of Warm Sunshine After the Cold Winter
5/15
Zero2IPO Insight
The statistics of Zero2IPO Research Center show that in the 28 first-batch ChiNext-listed companies, 23 were supported by a total of 46 VC/PE
institutions. Among them, four foreign VC/PE institutions accounted for 8.7%. They are Intel Products which had invested in Silver River, Warburg
Pincuss subsidiary Brook which had invested in Lepu Medical, IFC which had invested in Aier Ophthalmology; two joint venture VC/PE institutions
taking up 4.3% of the total are respectively China Equity which had invested in Huayi Brothers, and China-Belgium Fund which had invested in
Zhongyuan Huadian; A total of 40 local VC/PE institutions accounted for as high as 87.0%. Among them, Jiuding Capital and Gold Stone performed
more prominently each with two investees landing on ChiNext in the first batch, while Fortune VCs performance was undoubtedly the most eye-
catching one with 3 investees initially listed on ChiNext.
Table 2 46 VC/PE Institutions with Investment in First Batch of ChiNext-listed Enterprises
VC/PE Type No.of EnterprisesBacked
Company Name Stock Code Headquarters
Industry(Grade 1)
Industry(Grade 2)
SharesIssued(10,000shares)
Am. Financedin
PlanRMB100M
IssuePrice
P/ERatio
Fortune VC Domestic 3 Eve Battery 300014 Guangdong(ExcludingShenzhen)
Clean-tech CleanEnergy
2,200 2.06 18.00 54.56
Aier Ophthalmology 300015 Hunan Bio/Healthcar e
MedicalServices
3,350 3.40 28.00 60.87
ChinaNetCenter 300017 Shanghai Broad IT IT Services 2,300 2.42 24.00 63.16
Jiuding Capital Domestic 2 Gifore 300022 Sichuan Services Retail 2,240 1.98 17.75 57.26
Geeya Technology 300028 Sichuan Broad IT Broadcasting(DTV)
3,700 1.85 11.30 45.20
Gold Stone Domestic 2 Ultrapower 300002 Beijing Broad IT IT Services 3,160 5.03 58.00 68.80
Shenyang Siaxun 300024 Liaoning Broad IT Other ElectronicsProducts
1,550 2.79 39.80 62.90
QingdaoLaoshan
Domestic 1 TGOOD Electric 300001 Shandong Traditional ElectronicEquipment
3,500 4.00 23.80 52.76
5
-
8/14/2019 ChiNext a Touch of Warm Sunshine After the Cold Winter
6/15
Zero2IPO Insight
TechnologyInvestmentHuijinlifang Domestic 1 Ultrapower 300002 Beijing Broad IT IT Services 3,160 5.03 58.00 68.80
Guangdong
Tongying VC
Domestic 1 Nanfang Venilator 300004 Guangdong
(ExcludingShenzhen)
Traditional Machinery
Manufacturing
2,400 2.88 22.89 46.24
ShanghaiLeading
Investment
Domestic 1 Beijing Toared 300005 Beijing Traditional Others 1,700 2.20 19.80 53.10
ChongqingTechnology
VC
Domestic 1 LummyPharmaceuticals
300006 Chongqing Bio/Healthcar e
Pharmaceuticals/HealthProducts
2,300 1.44 16.50 47.83
Ningbo Junrun Domestic 1 Hanwei Electronics 300007 Henan Traditional ElectronicEquipment
1,500 1.80 27.00 60.54
JiachuanInvestment
Domestic 1 Bestway Marine 300008 Shanghai Services Consulting 1,260 1.21 27.80 40.12
ZichenInvestment
Domestic 1 Bestway Marine 300008 Shanghai Services Consulting 1,260 1.21 27.80 40.12
Good Capital Domestic 1 AnkeBiotechnology
300009 Anhui Bio/Healthcar e
Bio-engineering
2,100 1.66 17.00 46.83
Gaoxin VC Domestic 1 Lanxum 300010 Beijing Broad IT IT Services 2,650 2.76 18.00 51.49
China VentureCapital
Domestic 1 Beijing DinghanTechnology
300011 Beijing Broad IT Other ElectronicsProducts
1,362 2.16 37.00 82.22
Xingye VC Domestic 1 Beijing DinghanTechnology
300011 Beijing Broad IT Other ElectronicsProducts
1,362 2.16 37.00 82.22
SuzhouJinrong
Investment
Domestic 1 Xinning Logistics 300013 Jiangsu Traditional Logistics 1,500 1.40 15.60 45.48
Yiwen VC Domestic 1 Xinning Logistics 300013 Jiangsu Traditional Logistics 1,500 1.40 15.60 45.48
NingheInvestment
Domestic 1 Xinning Logistics 300013 Jiangsu Traditional Logistics 1,500 1.40 15.60 45.48
TaiheInvestment
Domestic 1 Xinning Logistics 300013 Jiangsu Traditional Logistics 1,500 1.40 15.60 45.48
6
-
8/14/2019 ChiNext a Touch of Warm Sunshine After the Cold Winter
7/15
Zero2IPO Insight
CMTECH Domestic 1 Xinning Logistics 300013 Jiangsu Traditional Logistics 1,500 1.40 15.60 45.48
BeijingTechnology
VC
Domestic 1 Beilu 300016 Beijing Bio/Healthcar e
Pharmaceuticals/HealthProducts
1,700 1.83 17.86 47.89
Infotech Domestic 1 Beilu 300016 Beijing Bio/Healthcar e
Pharmaceuticals/HealthProducts
1,700 1.83 17.86 47.89
LegendCapital
Domestic 1 ChinaNetCenter 300017 Shanghai Broad IT IT Services 2,300 2.42 24.00 63.16
CDF Capital Domestic 1 ChinaNetCenter 300017 Shanghai Broad IT IT Services 2,300 2.42 24.00 63.16
Beijing VisionInvestment
Domestic 1 ChinaNetCenter 300017 Shanghai Broad IT IT Services 2,300 2.42 24.00 63.16
SZVC Domestic 1 ChinaNetCenter 300017 Shanghai Broad IT IT Services 2,300 2.42 24.00 63.16
ShenzhenCareall VC
Domestic 1 ChinaNetCenter 300017 Shanghai Broad IT IT Services 2,300 2.42 24.00 63.16
Zhejiang
TechnologyVC
Domestic 1 Silver River 300020 Zhejiang Broad IT Software 2,000 1.70 20.00 52.63
HaitongKaiyuan
Domestic 1 Silver River 300020 Zhejiang Broad IT Software 2,000 1.70 20.00 52.63
ZhejiangLanshan
Domestic 1 Silver River 300020 Zhejiang Broad IT Software 2,000 1.70 20.00 52.63
CASInvestment
Domestic 1 Shenyang Siaxun 300024 Liaoning Broad IT Other ElectronicsProducts
1,550 2.79 39.80 62.90
ShenyangSengmu
Investment
Domestic 1 Shenyang Siaxun 300024 Liaoning Broad IT Other ElectronicsProducts
1,550 2.79 39.80 62.90
Tianjin VC Domestic 1 Chase Sun 300026 Tianjin Bio/Healthcar e
Pharmaceuticals/Health
Products
1,259 2.68 60.00 49.18
ChangshaXinao
Domestic 1 Geeya Technology 300028 Sichuan Broad IT Broadcasting(DTV)
3,700 1.85 11.30 45.20
HangzhouJiaze
Investment
Domestic 1 Geeya Technology 300028 Sichuan Broad IT Broadcasting(DTV)
3,700 1.85 11.30 45.20
7
-
8/14/2019 ChiNext a Touch of Warm Sunshine After the Cold Winter
8/15
Zero2IPO Insight
ShenzhenHangyuanFuchuang
Domestic 1 Geeya Technology 300028 Sichuan Broad IT Broadcasting(DTV)
3,700 1.85 11.30 45.20
HangzhouDehui
Investment
Domestic 1 Geeya Technology 300028 Sichuan Broad IT Broadcasting(DTV)
3,700 1.85 11.30 45.20
ShanghaiFlorin
Investment
Domestic 1 Geeya Technology 300028 Sichuan Broad IT Broadcasting(DTV)
3,700 1.85 11.30 45.20
ShanghaiFengze
Investment
Domestic 1 Geeya Technology 300028 Sichuan Broad IT Broadcasting(DTV)
3,700 1.85 11.30 45.20
Intel Capital Foreign 1 Silver River 300020 Zhejiang Broad IT Software 2,000 1.70 20.00 52.63
IFC Foreign 1 Aier Ophthalmology 300015 Hunan Bio/Healthcar e
MedicalServices
3,350 3.40 28.00 60.87
Brook Foreign 1 Lepu Medical 300003 Beijing Bio/Healthcar e
MedicalEquipment
4,100 5.17 29.00 59.56
Warburg
Pincus
Foreign 1 Lepu Medical 300003 Beijing Bio/Healthcar
e
Medical
Equipment
4,100 5.17 29.00 59.56
China Equity JVC 1 Huayi Brothers 300027 Beijing Services Media 4,200 6.20 28.58 69.71
China-BelgiumFund
JVC 1 ZhongyuanHuadian
300018 Hubei Traditional ElectronicEquipment
1,635 1.85 32.18 52.62
Source: Zero2IPO Research Center 2009.10 www.zero2ipo.com.cn
The First Batch of Listed Companies Is Best of the Best, in Which Beijings Enterprises Take the Majority.
From the point of view of geographical breakdown, the first batch of 28 ChiNext-listed companies are scattered among 17 provinces and cities
including Beijing, Sichuan, Shanghai, Guangdong (Excluding Shenzhen) and Zhejiang, among which Beijing had the most with seven enterprises--
Ultrapower, Lepu Medical, Toread and so on; Sichuan is also at the forefront, contributing three ChiNext-listed companies, namely, Chengdu Guibao,Gifore and Geeya Technology; Shanghai, Guangdong (Excluding Shenzhen) and Zhejiang have respectively two companies listed on ChiNext; in
addition, Shenzhen, Tianjin, Chongqing, Henan, Anhui, Hunan, Jiangsu, Hubei, Shandong, Liaoning, Shaanxi and Gansu also each have one
enterprise listed.
8
http://www.zero2ipo.com.cn/http://www.zero2ipo.com.cn/ -
8/14/2019 ChiNext a Touch of Warm Sunshine After the Cold Winter
9/15
Zero2IPO Insight
Table 3 First Batch of 28 ChiNext-listed Enterprises (By Headquarters)
Headquarters StockCode
CompanyName
Grade-1Industry
IssuePrice
P/ERatio
SharesIssued(10,000shares)
Amt.Finance
d inPlanRMB100M
GrossProfit
Rate in2008
NetProfit
Rate in2008
NetAssetsIncomeRatio in
2008
VC/PEInstitution
Year Round Investment Stage
Beijing 300002 Ultrapower Broad IT 58.00 68.80 3 ,160 5.03 50.36% 23.21% 51.58% Huijinlifang,Gold Stone
2009 A Expansionstage
300003 LepuMedical
Bio/Healthcare
29.00 59.56 4,100 5.17 78.58% 51.07% 39.35% WarburgPincus
2007 N/A Expansionstage
300005 BeijingToread
Traditional 19.80 53.10 1,700 2.20 45.17% 12.03% 27.95% BeijingLeading
Investment
2008 A Expansionstage
300010 Lanxum Broad IT 18.00 51.49 2,650 2.76 30.09% 13.69% 32.65% GaoxinInvestmentDevelopment
2008 A Expansionstage
300011 BeijingDinghanTechnology
Broad IT 37.00 82.22 1,362 2.16 52.16% 21.21% 21.14% ChinaVentureCapital
2007 A Expansionstage
Xingye VC 2009 B Expansionstage
300016 Beilu Bio/Healthcare
17.86 47.89 1,700 1.83 41.84% 14.71% 19.57% QingdaoLaoshanTechnologyInvestment
1999 A Earlystage
Infotech 2008 B Late stage
300027 HuayiBrothers
Services 28.58 69.71 4,200 6.20 53.74% 16.63% 27.44% ChinaEquity
2004 A Expansionstage
Sichuan 300019 ChengduGuibao
Traditional 23.00 47.96 1,300 1.63 40.61% 18.81% 34.07%
9
-
8/14/2019 ChiNext a Touch of Warm Sunshine After the Cold Winter
10/15
Zero2IPO Insight
300022 Gifore Services 17.75 57.26 2,240 1.98 13.52% 3.68% 29.57% JiudingCapital
2009 A Late stage
300028 GeeyaTechnology
Broad IT 11.30 45.20 3,700 1.85 47.13% 25.47% 20.22% Xinao VC,HangyuanfuVC,
Dehui
Investment,
Jiaze
Investment,
Florin
Investment,
Fengze
Investment,
Jiuding
Capital
N/A N/A Expansionstage
Shanghai 300017 ChinaNetCenter
Broad IT 24.00 63.16 2,300 2.42 35.50% 15.51% 25.98% CDF-Capital,Fortune VC,VIC, FuweiVC
2008 B Late stage
SZVC,Fortune VC
2007 A Expansionstage
300008 BestwayMarine
Services 27.80 40.12 1,260 1.21 48.30% 32.95% 46.53% ShanghaiZichenInvestment
2007 A Expansionstage
GuangdongExcluding
Shenzhen
300004 NanfangVentilator
Traditional 22.89 46.24 2,400 2.88 30.30% 15.13% 26.43% TongyingVC
2007 A Late stage
300014 Eve Battery Clean-
tech
18.00 54.56 2,200 2.06 24.78% 15.32% 24.91% CMTECH,
Fortune VC
N/A N/A Expansion
stageZhejiang 300020 Silver River Broad IT 20.00 52.63 2,000 1.70 25.41% 9.02% 19.34% ZVC,HaitongKaiyuan,ZhejiangLanshan
N/A A Expansionstage
10
-
8/14/2019 ChiNext a Touch of Warm Sunshine After the Cold Winter
11/15
Zero2IPO Insight
Intel Capital 2009 B Expansionstage
300025 HuaxingChuangye
Broad IT 19.66 45.18 1,000 1.18 45.17% 14.97% 29.60%
Shenzhen 300012 Center TestingInternational
Traditional 25.78 59.95 2,100 2.75 68.10% 21.87% 34.05%
Tianjin 300026 Chase Sun Bio/Healthcare
60.00 49.18 1,259 2.68 76.38% 34.43% 51.30% TJVC, etc. 2008 A Late stage
Chongqing 300006 Lummy Bio/Healthcare
16.50 47.83 2,300 1.44 36.11% 12.40% 23.87% ChongqingTechnologyVC
2007 A Expansionstage
Henan 300007 HenanHanweiElectronics
Traditional 27.00 60.54 1,500 1.80 59.03% 30.50% 32.53% NingboJunrunInvestment
2008 A Late stage
Anhui 300009 AnkeBiotechnology
Bio/Healthcare
17.00 46.83 2,100 1.66 70.91% 23.05% 24.26% Good VC 2005 A Late stage
Shandong 300001 TGOOD
Electric
Traditional 23.80 52.76 3,500 4.00 35.52% 22.58% 58.65% Qingdao
LaoshanTechnologyInvestment
2009 A Expansion
stage
Jiangsu 300013 XinningLogistics
Traditional 15.60 45.48 1,500 1.40 50.83% 16.45% 23.71% JinrongInvestment
N/A A Expansionstage
TaiheInvestment,YiwenVentureCapital,NingheInvestment
2007 B Expansionstage
Hunan 300015 Aier Ophthalmology
Bio/Healthcare
28.00 60.87 3,350 3.40 55.43% 13.59% 22.78% IFC 2006 A Expansionstage
Fortune VC 2007 B Expansionstage
Hubei 300018 Zhongyuan Huadian
Traditional 32.18 52.62 1,635 1.85 55.77% 39.38% 55.11% China-BelgiumFund
2009 A Expansionstage
11
-
8/14/2019 ChiNext a Touch of Warm Sunshine After the Cold Winter
12/15
Zero2IPO Insight
Gansu 300021 Dayu Water-saving
Traditional 14.00 53.85 1,800 1.53 23.14% 9.27% 14.42%
Shaanxi 300023 Bode EnergyEquipment
Traditional 19.60 81.67 1,500 1.60 21.06% 11.56% 38.72%
Liaoning 300024 STASUN
Robot &Automation
Broad IT 39.80 62.90 1,550 2.79 25.75% 11.93% 15.44% Gold Stone 2008 N/A Expansion
stage
SourceZero2IPO Research Center 2009.10 www.zero2ipo.com.cn
Through the first round of screening and counseling by all those brokerage firms, accountants, law firms before the listing, along with the successive
checks made by the Issuance Examination Committee of China Securities Regulatory Commission for ChiNext, the first batch of 28 listed companies
are of relatively good qualifications. Viewing from the financial indicators of enterprises landed on ChiNext in the first batch, 28 ChiNext-listed
enterprises go even farther than those listed on the Main Board, while they all achieved profits in previous three consecutive years. It fully reflects the
principle of selecting best among the best and prudent and conservative attitudes of regulatory authorities. On the other hand, viewing from the IPO
P/E ratio, the average IPO P/E ratio of ChiNext was 56.6 times, the highest one, Beijing Dinghan Technology, was even 82.22 times. Compared with
the average IPO P/E ratio of 25 times in A-share market and that of 40 times in Shenzhen SME Board, its high P/E ratios not only fully reflect investors
expectation on the high growth of enterprises, but also make people full of worry in excitement.
ChiNexts Future
In the long run, whether the qualifications of listed companies are excellent and the continued growth, innovation and competitiveness of enterprises
can be demonstrated after being listed, as well as what kind of impact will be left on the overall development of ChiNext are affected by the following
factors:
(1) China's economic stability would to some extent affect the scale of ChiNext development. At present, our macro-economy has emerged with trendsof leading the worlds economic recovery and stabilizing upwards. The pace of ChiNext listing progress will be smoother, and ChiNexts scope will
develop at a faster speed based on the favorable economic situation.
12
-
8/14/2019 ChiNext a Touch of Warm Sunshine After the Cold Winter
13/15
Zero2IPO Insight
(2) Adequacy of the resources of backup enterprises for listing. As for the successful historical experiences abroad, whether the backup enterprises for
listing are adequate determines the success to a certain extent: Taking NASDAQ as an example, the United States has numerous enterprise resources
which are in line with the conditions of listing in its innovative economic environment, the abundance of its resources determines the success of
NASDAQ; The success factors for KASDAQ of South Korea are similar to those of the United States. After the Asian financial crisis, economic systemreforms and establishments were carried out in South Korea to encourage business startups, hence fostering a batch of excellent enterprise
resources. However, the GEM of Hong Kong was not successful due to a lack of backup enterprise resources, which led to market liquidity shortage
and a weaker confidence of investors.
(3) Risk of excess liquidity. The launch ofChiNext will attract the attention of international speculators, resulting in the improper inflows of foreign "hot
money"; moreover, it is unavoidable that a large number of short-term capital for the purpose of profit-chasing will be poured into the market
domestically, which causes the stock market to rise suddenly and slump sharply, making the developing situation unstable in the overall market scope.
(4) Rigorous and complete supervisory system is the basis for protecting the markets normal operations. Only with the supervisory system of ChiNext
completed step by step, can the sudden rises and slumps, as well as the malignant speculations of share market be prevented effectively. It will also
strictly control the information disclosure of listed companies, preventing false information disclosure and even such problems as major shareholders
occupying the interests of listed companies and so on, to maintain the competition orders of ChiNext.
(5) With the cascade effect of the stock market, the ups and downs of A-share market will also affect the ChiNexts trend more or less. While a bull or
slow bull market appears in A-share market, the issuing and listing speed of ChiNext will be faster, but when A-share market is sluggish, ChiNexts
speed will be slowed down therewith.
(6) Enterprises operations after the listing. ChiNext mainly consists of small and medium high-tech firms, while the high growth of h igh-tech enterprises
accompanied with high risks at the same time, such as operation risk, faith risk, technology risk, market competition risk, financial risk, etc. They will allbe determining factors in the growth of listed companies, thereby influencing the overall development of ChiNext.
In addition, analyzing from the point of view of the stock prices for listed companies, the prices depend primarily on the two aspects, enterprises
13
-
8/14/2019 ChiNext a Touch of Warm Sunshine After the Cold Winter
14/15
Zero2IPO Insight
fundamentals and investors confidence. In the initial stage of ChiNext, because of the better qualifications of the first listed companies, investors are
full of confidence and market values are relatively high, while the stock prices fluctuating up and down with the value changes perform powerfully in
this period; Then, as ChiNext gradually steps into maturity and rationality, numerous listed companies will show different growth potentials and
competitiveness, there will be several layers appearing in their stock prices: Share prices for part of the companies with high growth, strongcompetitiveness and favorable fundamentals will gradually move up; other companies which face bottlenecks in development, decreased
competitiveness or severe calamity will be sluggish; while individual listed companies will be knocked out from ChiNext if significant financial problems
or false information disclosure and other incidents occur.
All in all, the timely launch of ChiNext in China has great significance. From the perspective of the development of domestic small and medium-size
enterprises (SMEs), it will shorten the timeframe from startups to listing for many national SMEs, allowing excellent new emerging enterprises which
can hardly obtain financing stand out as soon as possible to achieve independent growth and expansion through breaking the monopoly of big
enterprises. Secondly, as the barometer of innovations in business models and technologies, ChiNext can encourage more firms or individuals to
utilize business opportunities and models similar to those of listed enterprises. From the point of view of domestic and foreign VC/PE institutions, the
launch of ChiNext will bring more flexible and convenient exit options for them, thus motivating the investment enthusiasm of VC/PE agencies in
Chinas market. It will also promote the fund-raising of RMB funds, facilitating the industrial upgrades of VC investment, truly realizing the positive
cycles of internal capital domestically raised, invested and exited. Here we would like to wish ChiNext and Chinese VC/PE industry make further
progress and achieve more!
About Zero2IPO Research Center
Founded in November 2001, Zero2IPO Research Center provides professional research reports and customized industry reports for VC and PE funds,
government organizations, intermediaries and startup enterprises in Greater China Region. The centers research scope covers VC, PE, IPO, M&Aand high-tech industries. It has grown into the most professional and authoritative research institution in China.
Statement on Republication:
14
-
8/14/2019 ChiNext a Touch of Warm Sunshine After the Cold Winter
15/15
Zero2IPO Insight
The article is publicly released to media by Zero2IPO Group. Any questions and suggestions on data and research, please contact Ms. Leaf Zhang by
phone or email:
Tel: +86 10 84580476
Email: [email protected] in republication please mail two sample copies to:
Nicole Meng
Rm.1202/03, Tower A, Eagle Run Plaza, No.26, Xiaoyun Road, Chaoyang District, Beijing 100125
Or email the website link of your article to [email protected]. Thank you.
15
mailto:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]